These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8415869)

  • 1. Attenuation of ischemic acute renal failure by phosphoramidon in rats.
    Vemulapalli S; Chiu PJ; Chintala M; Bernardino V
    Pharmacology; 1993 Sep; 47(3):188-93. PubMed ID: 8415869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats.
    Vemulapalli S; Watkins RW; Brown A; Cook J; Bernardino V; Chiu PJ
    Life Sci; 1993; 53(10):783-93. PubMed ID: 8355566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoramidon-sensitive conversion of big endothelin-1 and degradation of endothelin-1 in rat kidney.
    Fujita K; Matsumura Y; Kita S; Hisaki K; Takaoka M; Morimoto S
    Hypertension; 1994 Aug; 24(2):227-33. PubMed ID: 8039848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats.
    Matsumura Y; Kuro T; Kobayashi Y; Umekawa K; Ohashi N; Takaoka M
    Jpn J Pharmacol; 2000 Sep; 84(1):16-24. PubMed ID: 11043448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage.
    Sharkovska Y; Kalk P; von Websky K; Relle K; Pfab T; Alter M; Fischer Y; Hocher B
    Clin Lab; 2011; 57(7-8):507-15. PubMed ID: 21888014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
    Trapani AJ; Balwierczak JL; Lappe RW; Stanton JL; Graybill SC; Hopkins MF; Savage P; Sperbeck DM; Jeng AY
    Biochem Mol Biol Int; 1993 Dec; 31(5):861-7. PubMed ID: 8136704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
    McMahon EG; Palomo MA; Brown MA; Bertenshaw SR; Carter JS
    Am J Hypertens; 1993 Aug; 6(8):667-73. PubMed ID: 8217029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic-natriuretic actions and pressor effects of big-endothelin (1-39) in phosphoramidon-treated rats.
    Hoffman A; Haramati A; Dalal I; Shuranyi E; Winaver J
    Proc Soc Exp Biol Med; 1994 Feb; 205(2):168-73. PubMed ID: 8108467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure activity relationship of phosphoramidon derivatives for in vivo endothelin-converting-enzyme inhibition.
    Bigaud M; Hauss B; Schalk C; Jauch MF; D'Orchymont H
    Fundam Clin Pharmacol; 1994; 8(2):155-61. PubMed ID: 8020872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ; Savage P; Sakane Y; Berry JC; Bilci NA; Ghai RD; Jeng AY
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhamnose moiety of phosphoramidon is not required for in vivo inhibition of endothelin converting enzyme.
    Pollock DM; Shiosaki K; Sullivan GM; Opgenorth TJ
    Biochem Biophys Res Commun; 1992 Jul; 186(2):1146-50. PubMed ID: 1497648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats.
    Vemulapalli S; Chiu PJ; Griscti K; Brown A; Kurowski S; Sybertz EJ
    Eur J Pharmacol; 1994 May; 257(1-2):95-102. PubMed ID: 8082712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endothelin-converting enzyme in the systemic hemodynamics and regional circulatory effects of proendothelin-1 (1-38) and diaspirin cross-linked hemoglobin in rats.
    Gulati A; Singh R; Chung SM; Sen AP
    J Lab Clin Med; 1995 Dec; 126(6):559-70. PubMed ID: 7490515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for endothelin in the renal responses to radiocontrast media in the rat.
    Oldroyd S; Slee SJ; Haylor J; Morcos SK; Wilson C
    Clin Sci (Lond); 1994 Oct; 87(4):427-34. PubMed ID: 7834995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoramidon, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats.
    Hassan M; Kashimura H; Matsumaru K; Nakahara A; Fukutomi H; Muto H; Goto K; Tanaka N
    Life Sci; 1997; 61(10):PL 141-7. PubMed ID: 9296343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGS 34226, a thiol-based dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11.
    Jeng AY; Savage P; Beil ME; Bruseo CW; Hoyer D; Fink CA; Trapani AJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():98S-101S. PubMed ID: 12193064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoramidon-sensitive endothelin converting enzyme in rat lung.
    Takaoka M; Shiragami K; Fujino K; Miki K; Miyake Y; Yasuda M; Wang GF; Hisaki K; Matsumura Y; Morimoto S
    Biochem Int; 1991 Nov; 25(4):697-704. PubMed ID: 1815503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of puromycin aminonucleoside-induced glomerular lesions in rats by CGS 26303, a dual neutral endopeptidase/endothelin-converting enzyme inhibitor.
    Feldman DL; Mogelesky TC; Chou M; Jeng AY
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S342-5. PubMed ID: 11078415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme.
    Nelissen J; Lemkens P; Sann H; Bindl M; Bassissi F; Jasserand D; De Mey JG; Janssen BJ
    Life Sci; 2012 Oct; 91(13-14):587-92. PubMed ID: 22365954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1.
    Pollock DM; Opgenorth TJ
    Am J Physiol; 1991 Jul; 261(1 Pt 2):R257-63. PubMed ID: 1650147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.